Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
October 1, 2019
Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping
Nick Baniak, C Blake Gilks, John DeCoteau, et al.
Cancer Research
|
January 21, 2010
The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells
Luke Truitt, Tanya Freywald, John DeCoteau, et al.
Journal of Translational Medicine
|
November 21, 2007
N-myristoyltransferase: a potential novel diagnostic marker for colon cancer
Anuraag Shrivastav, Shailly Varma, Anurag Saxena, et al.
Cancers
|
January 21, 2022
Imaging Immune Cells Using Fc Domain Probes in Mouse Cancer Xenograft Models
Wendy Bernhard, Kris Barreto, Ayman El-Sayed, et al.
Hematology Reports
|
June 26, 2024
Morphological Clues of Acute Monocytic Leukemia in COVID-19-Induced Transient Leukoerythroblastic Reaction with Monocytosis
Ingrid S Tam, Mohamed Elemary, John DeCoteau, et al.
Molecular Cancer Research : MCR
|
March 4, 2008
In human leukemia cells ephrin-B-induced invasive activity is supported by Lck and is associated with reassembling of lipid raft signaling complexes
Guangping Jiang, Tanya Freywald, Jarret Webster, et al.
Journal of Extracellular Vesicles
|
January 31, 2026
Antibody-Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy
Brijesh Parlekar, David W Livingstone, Ashley R Sutherland, et al.
Journal of Nanobiotechnology
|
October 18, 2024
Antibody-targeted T cells and natural killer cells for cancer immunotherapy
Ashley R Sutherland, Brijesh Parlekar, David W Livingstone, et al.
BMC Cancer
|
March 13, 2021
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
Wendy Bernhard, Kris Barreto, Ayman El-Sayed, et al.
Cellular Signalling
|
August 26, 2014
Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction
Odette Allonby, Amr M El Zawily, Tanya Freywald, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
October 1, 2019
Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping
Nick Baniak, C Blake Gilks, John DeCoteau, et al.
Cancer Research
|
January 21, 2010
The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells
Luke Truitt, Tanya Freywald, John DeCoteau, et al.
Journal of Translational Medicine
|
November 21, 2007
N-myristoyltransferase: a potential novel diagnostic marker for colon cancer
Anuraag Shrivastav, Shailly Varma, Anurag Saxena, et al.
Cancers
|
January 21, 2022
Imaging Immune Cells Using Fc Domain Probes in Mouse Cancer Xenograft Models
Wendy Bernhard, Kris Barreto, Ayman El-Sayed, et al.
Hematology Reports
|
June 26, 2024
Morphological Clues of Acute Monocytic Leukemia in COVID-19-Induced Transient Leukoerythroblastic Reaction with Monocytosis
Ingrid S Tam, Mohamed Elemary, John DeCoteau, et al.
Molecular Cancer Research : MCR
|
March 4, 2008
In human leukemia cells ephrin-B-induced invasive activity is supported by Lck and is associated with reassembling of lipid raft signaling complexes
Guangping Jiang, Tanya Freywald, Jarret Webster, et al.
Journal of Extracellular Vesicles
|
January 31, 2026
Antibody-Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy
Brijesh Parlekar, David W Livingstone, Ashley R Sutherland, et al.
Journal of Nanobiotechnology
|
October 18, 2024
Antibody-targeted T cells and natural killer cells for cancer immunotherapy
Ashley R Sutherland, Brijesh Parlekar, David W Livingstone, et al.
BMC Cancer
|
March 13, 2021
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
Wendy Bernhard, Kris Barreto, Ayman El-Sayed, et al.
Cellular Signalling
|
August 26, 2014
Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction
Odette Allonby, Amr M El Zawily, Tanya Freywald, et al.
Page
of 2